Contact

Category: Conditions Treated

Conditions Treated defines the validated veterinary diagnostic indications, pathological targets, and clinical scopes of practice where avermectin therapeutics provide proven therapeutic efficacy.

Foundational Pillars
Pharmacological Framework
Clinical Directory
Frequently Asked Questions

Foundational Clinical Pillars

Core Reference

The Longevity of Ivermectin: A Detailed Chronicle of Clinical Use Across Five Decades

Examines frequency limits, continuous therapy boundaries, and toxic accumulation risks.

Clinical Benchmark

How Long Has Ivermectin Been Around? A 50-Year History from 1974 to the Present

Evaluates medical statutory frameworks, prescription approvals, and regulatory requirements.

Safety Standard

Where Did Ivermectin Come From? The Discovery of Streptomyces avermitilis and Satoshi Ōmura

Avian parasitology overview, scalable flock dosing, and mite elimination protocols.

Pathological Indications, Diagnostic Staging & Spectrum Boundaries

The therapeutic utility of ivermectin is rooted in veterinary parasitology, targeting microfilariae, internal roundworms, and microscopic acariasis. Diagnostic verification through fecal flotation, microfilarial Knott’s testing, or deep skin scrapings is mandatory before initiating clinical pharmacotherapy.

In canine practice, the core indication remains monthly chemoprophylaxis against Dirofilaria immitis. For dermatological pathologies, generalized demodicosis caused by Demodex canis proliferation requires long-term daily microfilaricidal therapy to reduce mite densities until two consecutive monthly skin scrapings yield negative results.

Pathological ConditionPrimary PathogenTherapeutic Protocol Standard
Heartworm Disease (Prevention)Dirofilaria immitis (L3/L4)6 – 12 mcg/kg orally every 30 days continuously
Demodectic AcariasisDemodex canis300 – 600 mcg/kg orally daily until negative scrapings
Sarcoptic MangeSarcoptes scabiei var. canis200 – 400 mcg/kg SQ or oral every 14 days (2-4 doses)
Cheyletiellosis (Walking Dandruff)Cheyletiella yasguri200 – 300 mcg/kg orally every 14 days for 3 cycles

Sarcoptic mange (Sarcoptes scabiei var. canis), a zoonotic intensely pruritic dermatosis, responds rapidly to bi-weekly ivermectin administration. In poultry and avian medicine, Scaly Leg Mites (Knemidocoptes mutans) and Northern Fowl Mites are controlled through calibrated drop administration to the unfeathered skin or leg surfaces.

Topic Directory & Methodologies

Canine & Feline Parasitic Pathologies

Avian & Multi-Species Clinical Scope

Advanced Formulations & Protocols

Frequently Asked Clinical Questions

What primary conditions does ivermectin treat in dogs?

It is primarily prescribed for canine heartworm prevention, sarcoptic mange, demodectic mange, ear mites, and intestinal hookworms or roundworms.

Can ivermectin be used to treat bacterial or viral infections?

No. Ivermectin is an antiparasitic drug that has no established clinical efficacy against canine viral or bacterial infections at safe mammalian doses.

How do veterinarians confirm mange is cured before stopping treatment?

Treatment continues until two successive skin scrapings performed 30 days apart confirm the complete absence of living mites, larvae, and viable eggs.

Notice & Clinical Safe Harbor: This educational reference is maintained by the Veterinary Parasitology & Pharmacology Standards Desk for academic, informational, and clinical research purposes. Data models published veterinary pharmacology literature, statutory veterinary monographs, and established anthelmintic posology standards. This portal does not provide certified individual veterinary medical diagnosis, prescription services, or personalized treatment regimens. For clinical diagnoses, suspected parasitic toxicosis, and individualized dosing protocols, always consult an actively licensed veterinary practitioner in your jurisdiction.

AI Editorial Policy